The charge of using EPO, the performance-enhancing drug, proved to be a big career mistake for Manuel Beltran who was withdrawn from Tour de France by the Liquigas team.

The announcement was made after A sample of the cyclist taken from the first stage of the Tour tested positive.

From Espnstar.com:

Beltran finished the stage 25th. He finished Friday’s stage in 26th place, three minutes 20 seconds behind leader Kim Kirchen.

French daily L’Equipe first reported the positive test on its website.

Police responded to the news by raiding the hotel used by the Liquigas team, but the team plans to continue in the Tour without Beltran.

If the positive test is confirmed, Beltran, 37, would be the first rider to fail a doping test during this year’s Tour. Liquigas will await the results of a B sample before deciding whether to take further action against Beltran.

Earlier on Friday, the French anti-doping agency reported that tests conducted prior to the start of the Tour returned no positives tests but a few abnormalities.

The positive test was first reported by French daily L’Equipe on its official website.

Tags: EPO, Kim Kirchen, Manuel Beltranm Tour de France

Posted in buy steroids, Steroid Cycles, steroid nation, Steroids and Anabolic Steroids, Steroids in Olympics, Steroids in Sports